<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.02964.015</object-id><label>Table 1.</label><caption><p>Characterization and quantification of hemolymph of DAG species</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.02964.015">http://dx.doi.org/10.7554/eLife.02964.015</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Component name</th><th><italic>Sp</italic> &#8722; (&#181;g/ml)</th><th><italic>Sp</italic> + (&#181;g/ml)</th><th>% Of total mass decline</th></tr></thead><tbody><tr><td>C28:0 DAG</td><td align="char" char=".">13.4</td><td align="char" char=".">12.3</td><td align="char" char=".">7</td></tr><tr><td>C28:1 DAG</td><td align="char" char=".">0.8</td><td align="char" char=".">0.6</td><td align="char" char=".">1.2</td></tr><tr><td>C30:2 DAG</td><td align="char" char=".">0.7</td><td align="char" char=".">0.5</td><td align="char" char=".">1.2</td></tr><tr><td>C30:0 DAG</td><td align="char" char=".">0.1</td><td align="char" char=".">0.2</td><td align="char" char=".">&#8722;1.0</td></tr><tr><td>C32:3 DAG</td><td align="char" char=".">1.2</td><td align="char" char=".">1.1</td><td align="char" char=".">0.7</td></tr><tr><td>C32:2 DAG</td><td align="char" char=".">23.1</td><td align="char" char=".">21.8</td><td align="char" char=".">8.2</td></tr><tr><td>C32:1 DAG</td><td align="char" char=".">19.8</td><td align="char" char=".">15.1</td><td align="char" char=".">30.1</td></tr><tr><td>C34:2 DAG</td><td align="char" char=".">11.5</td><td align="char" char=".">10.8</td><td align="char" char=".">4.9</td></tr><tr><td>C34:1 DAG</td><td align="char" char=".">9.7</td><td align="char" char=".">6.9</td><td align="char" char=".">19.3</td></tr><tr><td>C34:0 DAG</td><td align="char" char=".">1.4</td><td align="char" char=".">0.5</td><td align="char" char=".">5.6</td></tr><tr><td>C36:4 DAG</td><td align="char" char=".">0.8</td><td align="char" char=".">0.5</td><td align="char" char=".">1.8</td></tr><tr><td>C36:3 DAG</td><td align="char" char=".">2.9</td><td align="char" char=".">2.2</td><td align="char" char=".">5.3</td></tr><tr><td>C36:2 DAG</td><td align="char" char=".">4.2</td><td align="char" char=".">2.9</td><td align="char" char=".">9.3</td></tr><tr><td>C36:1 DAG</td><td align="char" char=".">0.8</td><td align="char" char=".">0.9</td><td align="char" char=".">&#8722;0.3</td></tr><tr><td>C36:0 DAG</td><td align="char" char=".">1.7</td><td align="char" char=".">0.7</td><td align="char" char=".">6.9</td></tr><tr><td/><td align="char" char=".">92.1</td><td align="char" char=".">77</td><td/></tr></tbody></table><table-wrap-foot><fn><p>Quantification of the absolute concentration of individual DAG species in the hemolymph of <italic>Spiroplasma</italic>-uninfected (<italic>Sp</italic> (&#8722;)) and <italic>Spiroplasma</italic>-infected (<italic>Sp</italic> (+)) mated flies by LC-MS/MS. The % of total mass decline reflects the percentage of the total decline between <italic>Spiroplasma</italic>-uninfected and infected samples (a total of 15.1 &#956;g/ml or 16.3%) that can be attributed to each DAG species. It is notable that C32:1 and C34:1 DAG species decline to a greater extent than other common DAG species such as C28:0 and C32:2. This suggests that <italic>Spiroplasma</italic> is preferentially incorporating DAGs that have one saturated and one mono-unsaturated acyl chain. Notably, C34:1 DAGs are likely to be made up of oleic (C18:1) and palmitic (C16:0) acids, which have exactly the same acyl chains that were identified in <italic>Spiroplasma</italic>-generated cardiolipins (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p></fn></table-wrap-foot></table-wrap>